These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30197524)

  • 41. Antimicrobial Activity of Colistin Against Contemporary (2015 - 2017)
    Zhang H; Zhang G; Zhang J; Duan S; Kang Y; Yang Q; Xu Y
    Front Microbiol; 2020; 11():1966. PubMed ID: 33013738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of bla(OXA-like carbapenemase) and their insertion sequences (ISS) in the induction of resistance against carbapenem antibiotics among Acinetobacter baumannii isolates in Tehran hospitals.
    Asadollahi K; Alizadeh E; Akbari M; Taherikalani M; Niakan M; Maleki A; Asadollahi P; Soroush S; Feizabadi MM; Emaneini M
    Roum Arch Microbiol Immunol; 2011; 70(4):153-8. PubMed ID: 22568262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study.
    Cheng A; Chuang YC; Sun HY; Sheng WH; Yang CJ; Liao CH; Hsueh PR; Yang JL; Shen NJ; Wang JT; Hung CC; Chen YC; Chang SC
    Crit Care Med; 2015 Jun; 43(6):1194-204. PubMed ID: 25793437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran.
    Ezadi F; Jamali A; Heidari A; Javid N; Ardebili A
    J Glob Antimicrob Resist; 2020 Jun; 21():380-385. PubMed ID: 31770604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The efficacy of colistin monotherapy versus combination therapy with other antimicrobials against carbapenem-resistant
    Li J; Fu Y; Zhang J; Zhao Y; Fan X; Yu L; Wang Y; Zhang X; Li C
    J Chemother; 2020 Nov; 32(7):359-367. PubMed ID: 32427074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates.
    Lee H; Roh KH; Hong SG; Shin HB; Jeong SH; Song W; Uh Y; Yong D; Lee K
    Ann Lab Med; 2016 Mar; 36(2):138-44. PubMed ID: 26709261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carbapenemase Production of Clinical Isolates Acinetobacter baumannii and Pseudomonas aeruginosa from a Bulgarian University Hospital.
    Petrova AP; Stanimirova ID; Ivanov IN; Petrov MM; Miteva-Katrandzhieva TM; Grivnev VI; Kardjeva VS; Kantardzhiev TV; Murdjeva MA
    Folia Med (Plovdiv); 2017 Dec; 59(4):413-422. PubMed ID: 29341954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
    Oliva A; Scorzolini L; Cipolla A; Mascellino MT; Cancelli F; Castaldi D; D'Abramo A; D'Agostino C; Russo G; Ciardi MR; Mastroianni CM; Vullo V
    J Antimicrob Chemother; 2017 Jul; 72(7):1981-1984. PubMed ID: 28369424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resistotyping, phenotyping and genotyping of New Delhi metallo-β-lactamase (NDM) among Gram-negative bacilli from Iranian patients.
    Shokri D; Rabbani Khorasgani M; Fatemi SM; Soleimani-Delfan A
    J Med Microbiol; 2017 Apr; 66(4):402-411. PubMed ID: 28150578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
    Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
    Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growing OXA-23 type strains among carbapenem-resistant
    Altun Ş; Koçak Tufan Z; Altun B; Önde U; Kınıklı S; Demiröz AP
    Turk J Med Sci; 2016 Dec; 46(6):1894-1899. PubMed ID: 28081345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an
    Bian X; Liu X; Chen Y; Chen D; Li J; Zhang J
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Singkham-In U; Chatsuwan T
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):169-174. PubMed ID: 29433997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.
    Hong DJ; Kim JO; Lee H; Yoon EJ; Jeong SH; Yong D; Lee K
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):184-9. PubMed ID: 27475960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
    Hu YF; Liu CP; Wang NY; Shih SC
    BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia.
    Delgado-Valverde M; Conejo MDC; Serrano L; Fernández-Cuenca F; Pascual Á
    J Antimicrob Chemother; 2020 Jul; 75(7):1840-1849. PubMed ID: 32277821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant
    Mantzana P; Protonotariou E; Kassomenaki A; Meletis G; Tychala A; Keskilidou E; Arhonti M; Katsanou C; Daviti A; Vasilaki O; Kagkalou G; Skoura L
    Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.
    Jahangiri A; Neshani A; Mirhosseini SA; Ghazvini K; Zare H; Sedighian H
    Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In Vitro Activities of Tigecycline in Combination with Amikacin or Colistin Against Carbapenem-Resistant Acinetobacter baumannii.
    Wu H; Feng H; He L; Zhang H; Xu P
    Appl Biochem Biotechnol; 2021 Dec; 193(12):3867-3876. PubMed ID: 34524633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.